These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2304345)

  • 21. Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusions.
    Roseman JM
    J Surg Oncol; 1987 Jul; 35(3):170-2. PubMed ID: 3599991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose cisplatin for metastatic soft tissue sarcoma.
    Budd GT; Metch B; Balcerzak SP; Fletcher WS; Baker LH; Mortimer JE
    Cancer; 1990 Feb; 65(4):866-9. PubMed ID: 2297655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America.
    Castro DJ; Sridhar KS; Garewal HS; Mills GM; Wenig BL; Dunphy FR; Costantino PD; Leavitt RD; Stewart ME; Orenberg EK
    Head Neck; 2003 Sep; 25(9):717-31. PubMed ID: 12953307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma.
    Ellerbroek NA; Fossella FV; Rich TA; Ajani JA; Komaki R; Roth JA; Holoye PY
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):351-5. PubMed ID: 1846848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma.
    Albertini MR; Ranheim EA; Zuleger CL; Sondel PM; Hank JA; Bridges A; Newton MA; McFarland T; Collins J; Clements E; Henry MB; Neuman HB; Weber S; Whalen G; Galili U
    Cancer Immunol Immunother; 2016 Aug; 65(8):897-907. PubMed ID: 27207605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
    Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.
    Rietbroek RC; Bakker PJ; Schilthuis MS; Postma AJ; Zum Vörde Sive Vording PJ; Gonzalèz Gonzalèz D; Kurth KH; Bakker AJ; Veenhof CH
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):887-93. PubMed ID: 8598366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer effect of combined intratumor cisplatin injection and interstitial KTP laser therapy on xenografted squamous cell carcinoma.
    Chung PS; Kim HG; Rhee CK; Saxton RE
    J Clin Laser Med Surg; 2003 Feb; 21(1):23-7. PubMed ID: 12614556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae.
    Théon AP; Pascoe JR; Meagher DM
    J Am Vet Med Assoc; 1994 Oct; 205(8):1170-6. PubMed ID: 7890578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical study.
    Nicoletto MO; Padrini R; Palumbo M; Ziade A; Ragazzi RS; Pratesi G; Artioli G; De Cesare M; Zunino F
    Oncol Rep; 2002; 9(6):1351-4. PubMed ID: 12375047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
    Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
    Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus.
    Stahl M; Wilke H; Meyer HJ; Preusser P; Berns T; Fink U; Achterrath W; Knipp H; Harstrick A; Berger M
    Eur J Cancer; 1994; 30A(3):325-8. PubMed ID: 8204353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses.
    Théon AP; Pascoe JR; Madigan JE; Carlson G; Metzger L
    Am J Vet Res; 1997 Apr; 58(4):431-6. PubMed ID: 9099393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A patient with recurrent uterine cervical cancer successfully treated by combined modality therapy including local injection of anticancer agents based on CDDP].
    Shiota M; Shirai T; Tateyama I
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2117-21. PubMed ID: 11103245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
    Green DS; Bodman-Smith MD; Dalgleish AG; Fischer MD
    Br J Dermatol; 2007 Feb; 156(2):337-45. PubMed ID: 17223875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer.
    Polee MB; Verweij J; Siersema PD; Tilanus HW; Splinter TA; Stoter G; Van der Gaast A
    Eur J Cancer; 2002 Jul; 38(11):1495-500. PubMed ID: 12110496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.